ArticleJournal of clinical medicine2022

Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.

Salvatore D'Angelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.